There are at least two types of glial cells in the PNS, satellite cells surrounding neuronal perikarya in ganglia, and Schwann cells surrounding axons (Tennyson and Gershon, 1984; Thomas and Ochoa, 1984) . All axons are ensheathed by Schwann cells, but myelin is only made by Schwann cells under certain circumstances (Peterson and Murray, 1955; Peters and Vaughn, 1970; Voyvodic, 1989) . It is likely that neurite outgrowth, Schwann cell ensheathment of axons, and myelination require complex interactions between axons and Schwann cells (Aguayo et al., 1976; Weinberg and Spencer, 1979; Politis et al., 1982 ). There appears to be an initial recognition between the two cell types that then leads Schwann cells either only to surround axons or also to myelinate them. The signal to myelinate is provided by axons of a certain diameter (Friede and Samorajski, 1968; Voyvodic, 1989) and may (Sobue et al., 1986) or may not ) depend on activation of adenylate cyclase.
One approach to understanding the mechanism of Schwann cell-axon interactions is to study expression of molecules on the surfaces of Schwann cells and axons during development and regeneration of peripheral nerves (Trapp et al., 198 1; Poduslo, 1984) . These molecules can be studied by observing conditions under which they are expressed in vivo and in vitro and correlating their expression with development and maturation of the axon-Schwann cell unit.
Nonmyelinating Schwann cells express glial fibrillary acidic protein, A5E3, Ran-2, 217c(Ran-l), NCAM, and Ll/NgCAM (Yen and Fields, 198 1; Jessen et al., , 1990 Mirsky et al., 1986) , while myelin-forming cells do not. The myelin proteins PO, PI, P2, and myelin-associated glycoprotein are found exclusively in myelin-forming Schwann cells (Trapp et al., 198 1; Brostoff, 1984; Sutcliffe, 1987) . During development, both Schwann cells and axons express Ll/Ng-CAM and NCAM when they first come in contact; however, these cell adhesion molecules are sharply downregulated during myelination (Martini and Schachner, 1986; Ktinemund et al., 1988) while myelin-associated glycoprotein first appears at this time (Martini and Schachner, 1986) . Schwann cells and axons not involved in myelination continue to express L 1 and NCAM into adulthood (Seilheimer and Schachner, 1987) . Galactocerebroside (GC) (Jessen et al., 1985) sulfatide as recognized by antibody A007 ) and the S 100 protein (Stefansson et al., 1982a) are expressed by both myelinating and nonmyelinating Schwann cells.
Schwann cells have been cultured in the presence or absence of axons making it possible to deduce the effects of axons on expression of Schwann cell molecules (Kreider et al., 1981) . Schwann cells continue to express Ran-1 (Brockes et al., 1977) and the SlOO protein (Brockes et al., 1979) in the absence of continuous axonal contact, whereas the myelin proteins (Brockes et al., 1980 (Brockes et al., , 1981 Mirsky et al., 1980) P170k (Shuman et al., 1988 ) GC (Mirsky et al., 1980) and sulfatide recognized by antibodies 04 and A007 are sharply downregulated. Activation of adenylate cyclase induces in cultured Schwann cells the expression of GC (Sobue and Pleasure, 1984; Sobue et al., 1986) sulfatide ) and the myelin proteins PO and Pl (Lemke and Chao, 1988) .
The investigation of these Schwann cell markers and the conditions under which they are or are not expressed has increased our understanding of the function of these molecules as well as our understanding of the complex system of axon-Schwann cell interactions. We have identified in peripheral nerve and begun to characterize a 170,000 Da glycoprotein, which we call the Schwann cell membrane glycoprotein (SAG). SAG is probably, but not definitely, the same as a protein that has previously been described under the term P170k (Shuman et al., 1983) . We postulate that SAG may be a cell adhesion molecule involved in interactions between Schwann cells and axons.
Materials and Methods
Tissue samples. Human samples including cauda equina were obtained at autopsy performed less than 24 hr after death. Bovine spinal roots were obtained from a local vendor less than 2 hr after death and transported on ice. Lewis rats were obtained from Harlan Sprague Dawley. Fifteen neurofibromas and 15 schwannomas were retrieved from the archives of the Department of Pathology at the University of Chicago. The diagnoses were ascertained by two of the authors who are boardcertified neuropathologists (KS. and R.L.W.) by determining that the tumors fulfill classic histologic criteria (Russel and Rubinstein, 1989) and the cells express the S 100 protein (Stefansson et al., 1982b) .
Purification. Sciatic nerves were harvested from Lewis rats and stored at -70°C until needed. All steps in the enrichment procedure were performed at 4°C with the exception of gel filtration, which was performed at room temperature. Myelin isolation was performed according to the method of Norton and Poduslo (1973) . The rat peripheral nerve (PN) myelin was Dounce homogenized in 1% (v/v) NP-40 in buffer A (50 mM Tris, 150 mM sodium chloride, 1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, pH 7.6) and nutated for 1 hr. This mixture was centrifuged at 50,000 x g for 30 min, and the supematant was discarded. The resulting pellet was nutated with 5% NP-40 in buffer A for 1 hr and again centrifuged at 50,000 x g for 30 min. The pellet was washed twice with buffer A, centrifuged as above, incubated with 1% deoxycholate in buffer A for 1 hr, and centrifuged at 5?,000 x g for 30 min. The supematant was collected and loaded onto a gel filtration column (Superose 6) run with an FPLC machine (Pharmacia) using 1% deoxycholate in buffer A as the running buffer. The first peak after the void volume was collected, and some of the deoxycholate was removed with Bio-Beads SM2. mesh 20-50 (Bio-Rad). using the method of Horigome and Sugano (1983). The resulting solution was then dialyzed against distilled water and lyophilized. For the purpose of amino acid sequencing, SAG was isolated from the 1% deoxycholate extract with two additional methods, first, by using preparative polyacrylamide gel electrophoresis (PAGE) and electroelution and, second, by using PAGEseparated proteins from the 1% deoxycholate extract blotted onto an Immobilon membrane (Millipore, Bedford, MA) and excising the SAG band.
Antibodies. Monoclonal antibodies (mAbs) to P2 protein and SAG were raised by repeatedly immunizing Lewis rats with bovine P2 protein prepared by the method of Brostoff et al. (1975) . SAG is a trace contaminant when P2 is isolated utilizing this method but appears to be very immunogenic to the rat. The fusion of rat splenocytes and SP2/0 AG14 mouse myeloma cell line was performed according to a modification of a technique developed by Kohler and Milstein (1976; Gomez et al., 1979) . Six mAbs to SAG were raised, and their specificites were determined by testing them extensively on immunoblots containing polypeptides from homogenates of various tissues as well as on isolated proteins. Antibodies to SlOO (Molnar et al., 1984) and sulfatide (A007) were previously developed in our laboratory. A hybridoma producing anti-HNK-1 antibody was obtained from the American Type Tissue Collection (ATTC, Rockville, MD). A rabbit nolvclonal antiserum to GC was nrovided by Dr. J. A. Beniamins, Wayne State University (Dyer andBenjamins; . Immunohistochernistry and immunochemistry. Sections (6 pm) from formalin-fixed paraffin-embedded blocks of human autopsy or surgical material were used for the peroxidase-antiperoxidase (PAP) method of immunolocalization (Stemberger, 1979, pp. 104-169) . Rat PAP complexes were obtained from Stemberger-Meyer Immunocytochemicals Inc. (Jarretsville, MD). Coverslips of PC1 2 and RT4D4 cells were stained using indirect immunofluorescence (Stemberger, 1979, pp. 24-58) . Photographs were taken using either a Bio-Rad MRC 500 confocal microscope or a Leitz Diaplan microscope for fluorescence and bright field using Nomarski optics.
PAGE, immunoblots, and lectin binding. Protein samples and molecular weight standards (Bio-Rad Laboratories, Richmond, CA) were solubilized in 5.7 M urea, 1% (w/v) SDS, and 1% (v/v) 2-mercaptoethanol, with pyronin Y used as a dye, and heated at 100°C for 3 min. The polypeptides in the samples were separated on a 0.75 mm SDS-PAGE gel using 6% polyacrylamide and 0.2% cross-linking as described by Lugtenberg et al. (1975) . Gels were either directly stained with silver nitrate (Merril et al., 1984) or the polypeptides were electrically transferred from the gels onto a nitrocellulose membrane (Towbin et al., 1979) . Western blotting and lectin staining were performed as previously described (Mikol and Stefansson, 1988 Amino acid sequencing. The samples used for the amino acid sequencing included a preparation enriched for SAG using detergent solubilization and gel filtration chromatography as described above, SAG isolated using preparative electrophoresis, and SAG excised from an Immobilon membrane. Protein sequence analysis was performed with automated Edman degradation in an Applied Biosystems Model 470A gas-phase sequencer fitted with an on-line HPLC analyzer (model 120A) for phenylthiohydantoins.
Peaks from the latter were integrated by a Nelson Analytical 2700 series chromatography data system connected in parallel with the recorder to the output of the model 120A HPLC system. The National Biomedical Research Foundation database and the FASTP and GAP programs from the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) were employed in searches for sequence similarity.
PC12 and schwannoma culture. Rat schwannoma cell line RT4D4 (kindly provided by Dr. G. Dawson, The University of Chicago, Chicago, IL) (Imada and Sueoka, 1978) was passaged every 4 d in Dulbecco's modified Eagle's medium (MEM) with 10% fetal calf serum (FCS) and penicillin/streptomycin.
The rat pheochromocytoma cell line PC12 (kindly provided by Dr. B. Wainer, The University of Chicago, Chicago, IL) was passaged every 4 d in Dulbecco's MEM with 10% FCS. A C6 glioma cell line was obtained from ATTC and passaged every 4 d in Dulbecco's MEM with 10% FCS. The co-culture experiments were performed in Linbro 24-well culture plates (Flow Laboratories, Inc., VA) with poly+lysine-coated coverslips in each well. PC 12 or C6 glioma cells were plated at 1 x lo5 cells/well. After 3 d in culture, 1 x lo5 RT4D4 cells were added to each well and the cells were cocultured for 4 d before antibody staining. The cell numbers and timing were ontimized for maximum SAG staining. Conditioned medium was prepared from PC 12 cells by taking the supematant from PC 12 cells cultured for 4 d at 1 x lo5 cells per well. RT4D4 cells were cultured until the cells were confluent or for 3 d on poly-L-lysine-coated coverslips at 1 x 1 OS cells per well, the supematant aspirated, and the PC12 supematant added. The RT4D4 cells were stained 4 d later.
RT4D4 cells were cultured on coverslips in the presence or absence of 2 x 1O-4 M forskolin for 4 d (cells observed to be confluent) prior to antibody staining.
Results

Identijication
and distribution We raised mAbs to a polypeptide from PN with an apparent molecular weight of approximately 170,000 (Fig. 1 ). This 170 kDa polypeptide, referred to as SAG, is detectable on immunoblots containing polypeptides from rat, bovine, rabbit, and human PN. SAG is, however, not found in tissue samples taken from human brain, spinal cord, thyroid, lung, kidney, or testes (data not shown). The six mAbs raised were of the IgM isotype, and all had the same specificity by immunoblots and immunohistochemistry.
Immunohistochemical staining with mAbs to SAG demonstrates reactivity only with PN tissue (Fig. 2) . No staining is seen on tissue sections from brain, spinal cord, striated muscle, spleen, testes, lung, thyroid, skin, liver, heart, small intestine, or kidney except where PN is present within the tissue. The staining is in both myelinated and unmyelinated nerves, as can be seen when immunohistochemical staining for SAG and the P2 protein are compared in a cross section of a branch of the sciatic nerve (Fig. 2) or in a longitudinal section of the sympathetic trunk. The staining for the P2 protein is much more restricted than for SAG and at the same time more intense, making it unlikely that restricted distribution of P2 is caused by less sensitivity of the method used for its detection. It is also clear from Figure 2A that the satellite cells of sympathetic ganglia do not stain for SAG, which is also the case with satellite cells of dorsal root ganglia and of the myenteric plexus (data not shown). SAG does not appear to be in compact myelin, but on some cross sections of myelinated fibers there appears to be staining of either the periaxonal myelin or the outermost aspect of the myelin or both (Fig. 3) . However, this observation is based on light microscopy and should be considered only indicative of the subcellular distribution of SAG.
A Western blot containing electrophoresed polypeptides from developing rat peripheral nerves and stained with an mAb to SAG shows a barely detectable amount of SAG at embryonic day 2 1 (E2 l), a large increase in SAG concentration between E21 and postnatal day 0 (PNDO), and then a gradual increase in SAG concentration up to PND 15. There is a slight decrease in SAG concentration between PND 15 and adulthood (Fig. 4) . This experiment was done twice, and the results were the same both times. In the rat, myelination of PN begins at approximately PND2, with the most rapid rate of myelination being from PNDlO through PND20 (Friede and Samorajski, 1968) . Therefore, the period of greatest increase in SAG concentration in rat sciatic nerve occurs prior to myelination.
Plexiform neurofibromas are tumors of Schwann cells with axons running through them. Some tumor cells in neurofibromas stain for SAG in a distribution that follows axonal elements within the tumor (Fig. 5) . As expected, most of the tumor cells stain for the SlOO protein (Stefansson et al., 1982b ) but P2 protein is detected only in the myelinated fibers at the outskirt of the tumors. Schwannomas are tumors of Schwann cells without axons in them, and in contrast to neurofibromas, none of their tumor cells contain SAG (Fig. 6) .
In vitro expression
The rat schwannoma cell line RT4D4 does not express SAG when grown in Dulbecco's MEM with 10% FCS. Activation of adenylate cyclase with forskolin, which increases expression of many myelin components in Schwann cells (Sobue and Pleasure, 1984; Sobue et al., 1986; Lemke and Chao, 1988; Jessen et al., 1990) , does not induce expression of SAG in confluent or subconfluent cultures of RT4D4. However, forskolin dramatically increases expression of an epitope recognized by an antibody raised in our laboratory called A007 that reacts with sulfatide ( Fig. 7) .
When the RT4D4 cells are co-cultured with PC1 2 cells for 3 or more days, SAG appears in the RT4D4 cells (Figs. 8, 9 ). SAG does not appear in co-cultures of RT4D4 cells and C6 glioma cells (data not shown). Induction of SAG may require cell-to-cell contact because applying conditioned medium from PC12 cells onto the RT4D4 cells is not sufficient to induce expression (data not shown). Co-culture of RT4D4 and PC12 cells also leads to expression of GC on RT4D4 cells. Only RT4D4 cells in contact with PC 12 cells express SAG and GC; however, it is not clear whether all RT4D4 cells in contact with a PC12 cell express SAG and GC. Furthermore, it is not clear whether contact with PC 12 processes is necessary for induction of SAG expression or contact with PC12 cell bodies suffices.
Pur$cation SAG was extracted from rat sciatic nerve by making use of its relative insolubility. SAG is not soluble in 8 M urea, 1% Triton X-100, 1 M KCl, 1% CHAPS, 5% NP-40, 6 M guanidine HCl, or 30% acetonitrile, while it is soluble in 1% deoxycholate and 1% SDS. The solubility profile closely resembles that of PO protein (Roomi et al., 1978) for which a purification scheme based on solubility was developed (Kitamura et al., 1976) . We used a modification of this scheme and extracted PN myelin with 1% and 5% NP-40 each for 1 hr and a 50,000 x g pellet from the 5% NP-40 extract was solubilized in 1% deoxycholate. A 50,000 x g supematant of the 1% deoxycholate extract was run over a gel filtration column (Superose 6), and the first peak following the void volume was collected and reacted with BioBeads SM-2 to remove the deoxycholate partially. The resulting solution was then dialyzed against distilled water and lyophilized. Analysis on a silver-stained SDS-PAGE gel showed only one major band (Fig. lo) , but as demonstrated with N-terminal sequencing, this preparation was contaminated with the PO protein. However, using this preparation as an immunogen, we were able to raise polyclonal antibodies that are specific for SAG and do not react with the PO protein.
Carbohydrate
Lectin staining of Western blots of isolated rat SAG demonstrated binding to Ulex europaeus agglutinin I, peanut agglutinin, and WGA, but not Con A (data not shown). Bovine SAG purified from cauda equina contains the HNK-1 carbohydrate (Fig. l) , whereas rat SAG does not. Based on lectin staining, P2 protein is present in the compact myelin, in contrast to SAG, which in myelin appears to be confined to the outermost and periaxonal parts of the myelin (C, arrow) and is also in the unmyelinated parts of the sympathetic trunk (A). See Figure 3 for higher-power view.
tissue distribution, and size, SAG is likely to be the same as, or closely related to, a 170 kDa glycoprotein described by Shuman et al. (1983) and called P170k. rified, then run with SDS-PAGE, followed by transfer to an Immobilon membrane. The membrane was stained with Coomassie blue, and the band at 170 kDa was excised. Sequence analysis of this material gave one sequence in low yield. The second preparation sequenced was SAG enriched using the method described above. This sample contained more material of lesser purity than the first sample sequenced, and was composed of a predominant protein (75%), the sequence of which corresponded to the PO protein. The minor protein component (25%) gave a sequence that agreed with, and extended that obtained from analysis of, SAG blotted onto the Immobilon membrane. The preparation enriched for SAG was heavily contaminated with myelin PO protein despite having only a single band corresponding to 170 kDa on a silver-stained SDS-PAGE gel (Fig. 10) . A third sample was prepared by electroeluting a band 200-1 .a_*_ -116-E2l PO P2 P4 P6 PI0 P15 Ad corresponding to SAG from PAGE. This sample was without contamination and yielded a sequence that was identical to the other two. The sequence, shown in Figure 11 , did not match any protein in the databases searched, nor was there close similarity to a previously described protein.
Discussion
In this article we describe a PN glycoprotein we call SAG, which may be the same as, or closely related to, a previously described protein called P170k (Shuman et al., , 1988 . SAG has proven to be a difficult protein to work with because it has a tendency to degrade during attempts at isolation, despite application of protease inhibitors. Bovine and human SAG seem to be more susceptible to degradation than rat SAG. However, rat SAG yields degradation products that show up as minor bands on immunoblots. We were able to enrich for SAG to the extent that we could obtain its N-terminal sequence, which is distinct from known polypeptide sequences. The N-terminal sequence of SAG has a predominance of hydrophobic amino acids and does not display the pattern of charged and hydrophobic residues characteristic of signal sequences (von Heijne, 1984) . This region could form a transmembrane a-helical structure anchoring SAG to the cell membrane.
Our results demonstrate that SAG is confined to the PNS, is in PN prior to myelination, and is present in both myelinating and nonmyelinating Schwann cells. SAG does not appear to be present in compact myelin, but these data are based on light microscopy and definitive immunoelectron microscopy has not been performed. Hence, although some SAG is present in preparations of peripheral myelin, it is not confined to myelin, and it is probably more accurate to view it as a Schwann cell protein rather than a true myelin protein such as PO, P 1, or P2. However, this does not preclude the possibility that SAG may play a role in myelination or contribute to the stability of the myelin sheath. SAG is not present in satellite cells of peripheral ganglia, which are in contact with neuronal perikarya rather than axons. SAG Figure 7 . Culture ofa rat schwannoma cell line, RT4D4, stained using fluorescein isothiocyanate (FITC) indirect immunofluorescence and visualized with a confocal microscope. Culture A was grown in the presence of forskolin and stained with an mAb to sulfatide (AO07). Culture B was grown without forskolin and stained with mAb A007. Culture C was grown in the presence of forskolin and stained with an mAb to SAG. Culture D was grown without forskolin and stained with an mAb to SAG. In each case the corresponding bright-field micrograph using Nomarski optics is to the right. Forskolin does not induce expression of SAG in RT4D4 cells; however, expression of sulfatide is induced by forskolin in these cells. Scale bars, 25 pm. is expressed by neurofibromas, which contain axonal elements, but not by schwannomas, which are Schwann cell tumors devoid of axons; this suggests that presence of axons may be necessary for cells of Schwann cell lineage to express SAG.
Further support for the possibility that neuronal contact is necessary for the expression of SAG comes from the co-culture experiments. Schwannoma cells alone in culture or when cocultured with C6 glioma cells do not express SAG, whereas the schwannoma cells co-cultured with PC 12 cells do. Since supernatants from PC 12 cultures do not induce expression of SAG, the induction may require membrane contact. However, the Forskolin does not induce expression of SAG in schwannoma cells, indicating that the signal from the PC12 cells to the schwannoma cells is not received by a CAMP-dependent mechanism. This is in contrast to the myelin proteins PO and Pl, Figure 9 . Co-culture of RT4D4 cells with PC12 cells stained using immunofluorescence. The culture was stained with a rabbit polyclonal antibody to GC followed by tetramethylrhodamine isothiocyanate-conjugated swine anti-rabbit (A) and an mAb to SAG followed by FITCconjugated rabbit anti-rat(B). A bright-field micrograph using Nomarski optics of the same field is shown in C. All cells expressing SAG in the co-culture also express GC and are therefore considered schwannoma cells. Figure IO . Enrichment of SAG: silver stain of an SDS-PAGE gel containing the steps in the SAG enrichment scheme from rat PN. Lane A contains protein from unfractionated rat sciatic nerve. Myelin was isolated from rat PN (lane B). which was extracted with NP-40 and pelleted. This pellet (lane ?) was'kxtracted with 1% deoxycholate, and the supematant (lane D) was shown to be homogeneous SAG by silver stain. However, N-terminal sequencing showed it to be contaminated with PO protein.
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which are induced in cultured Schwann cells by forskolin (Lemke and Chao, 1988) . In addition, these results differ from those of Shuman et al. (1988) who found P170k to be forskolin inducible in cultured rat Schwann cells. However, it is important to emphasize that the experiments described here were done with a schwannoma cell line whereas Shuman et al. (1988) worked with primary cultures of Schwann cells. The PC 12 cell line is also a tumor cell line, and it could be argued that using a neuronal tumor cell line to induce expression of a protein on the surface of a schwannoma cell line constitutes a nonphysiologic system. However, rat schwannoma cell lines have been shown to support neurite outgrowth and the PC1 2 cell line has been used productively to study neuronal properties; for example, it was used in studies of molecules that are important for neurite extension (Tomaselli et al., 1987 (Tomaselli et al., , 1990 .
Interactions between PC1 2 and Schwann cells have previously been studied, and it has been determined that Schwann   5   10   15 The Journal of Neuroscience, June 1992, 72(6) 2183 cells are not able to ensheath PC12 net&es, assemble basal lamina, or differentiate when co-cultured with PC1 2 cells (Cochran, 1985) . However, there are interactions between Schwann cells and PC1 2 cells that lead to changes in morphology and mitotic rate of the cells (Cochran and Black, 1985) , although they do not lead to ensheathment or myelination. Therefore, it is likely that the molecules involved in this interaction are also involved in early interactions between Schwann cells and axons. Schwannoma cells do express SAG when co-cultured with PC1 2 cells, and SAG may therefore be such a molecule. This conclusion is, in part, based on the assumption that Schwann cell ensheathment of the axon, which is a process distinct from myelination, is also distinct from the early interactions between the Schwann cell and the axon.
When viewed together, the results of the study on the tissue distribution of SAG and the results of the co-culture experiments constitute compelling circumstantial evidence in support of the possibility that expression of SAG on Schwann cells is induced by contact between Schwann cells and neurons. Furthermore, the presence of SAG on Schwann cells and absence from satellite cells of ganglia indicate that contact with axons may be required for SAG expression and contact with perikarya is not sufficient.
SAG carries the HNK-1 carbohydrate, which is characteristic of many adhesion molecules (McGarry et al., 1983; Kruse et al., 1984 Kruse et al., , 1985 and may in itself be capable of mediating adhesion (Kiinemund et al., 1988) . Therefore, it is tempting to postulate that SAG may be responsible for some aspects of Schwann cell-axon adherence. However, since SAG is not expressed in a constitutive fashion on Schwann cells, it is probably not responsible for the original binding of Schwann cells to axons. In addition, since SAG is expressed not only in the adaxonal part of the myelin sheath but also in the abaxonal part (not in compact myelin), it is possible that the role of SAG is not limited to Schwann cell-axon interactions.
The expression of SAG may be regulated in a distinct manner. In Schwann cell cultures, myelin proteins are downregulated in the absence of continuous axonal stimulation (Brockes et al., 1979, 198 1) . Ran-l (Brockes et al., 1977) and SlOO protein (Brockes et al., 1979) are constitutively expressed by Schwann cells, and NCAM and L 1 /NgCAM (Nieke and Schachner, 1985; Daniloff et al., 1986) are upregulated in the absence of axons. SAG is the only protein we know of, not confined to myelin, that is probably dependent on continuous axonal signals. The regulation of SAG is most reminiscent of CC and sulfatide, both ofwhich are present in myelinating and nonmyelinating Schwann cells and require axonal input for continued expression (Jessen et al., 1985 (Jessen et al., , 1987 . However, the regulation of these glycolipids is thought to be through CAMP-dependent mechanisms (Sobue et al., 1986; Mirsky et al., 1990) . The expression of SAG appears to be regulated in a different manner and may therefore have a unique function in Schwann cell-axon interactions. 
